Amalgamated Bank’s Immunomedics Inc IMMU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-41,650
Closed -$3.54M 1611
2020
Q3
$3.54M Sell
41,650
-1,065
-2% -$53.9K 0.15% 108
2020
Q2
$1.51M Buy
42,715
+10,081
+31% +$295K 0.07% 253
2020
Q1
$440K Buy
32,634
+358
+1% +$6.02K 0.01% 968
2019
Q4
$683K Buy
32,276
+1,852
+6% +$32.7K 0.01% 969
2019
Q3
$403K Sell
30,424
-392
-1% -$5.76K 0.01% 1162
2019
Q2
$427K Buy
30,816
+9,291
+43% +$140K 0.01% 1159
2019
Q1
$413K Buy
21,525
+904
+4% +$14.6K 0.01% 1093
2018
Q4
$294K Buy
+20,621
New +$409K 0.01% 1184
2018
Q3
Sell
-19,954
Closed -$472K 1693
2018
Q2
$472K Buy
19,954
+6,415
+47% +$129K 0.01% 1060
2018
Q1
$198K Sell
13,539
-210
-2% -$3.43K 0.01% 1464
2017
Q4
$222K Buy
13,749
+968
+8% +$11.4K 0.01% 1441
2017
Q3
$179K Sell
12,781
-130
-1% -$1.3K 0.01% 1470
2017
Q2
$114K Buy
12,911
+966
+8% +$6.78K ﹤0.01% 1510
2017
Q1
$77K Sell
11,945
-24
-0.2% -$122 ﹤0.01% 1459
2016
Q4
$44K Buy
+11,969
New +$35.4K ﹤0.01% 1485
2016
Q2
Sell
-10,228
Closed -$26K 1409
2016
Q1
$26K Buy
+10,228
New +$23K ﹤0.01% 1276
2015
Q4
Sell
-10,150
Closed -$17K 1283
2015
Q3
$17K Buy
+10,150
New +$25.9K ﹤0.01% 1298

Amalgamated Bank's IMMU Position: Q4 2020 in Review

Amalgamated Bank sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 41,650 shares — an estimated $3.54M sold.

Amalgamated Bank first reported a position in IMMU in Q3 2015 and held it in 17 quarters. The position peaked at $3.54M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Amalgamated Bank reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Amalgamated Bank sold 41,650 Immunomedics Inc shares in Q4 2020, an estimated $3.54M.
  • Amalgamated Bank first reported a position in Immunomedics Inc in Q3 2015 and held it in 17 quarters.
  • Amalgamated Bank's Immunomedics Inc position peaked at $3.54M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Amalgamated Bank's 13F filing for Q4 2020, filed 12 Feb 2021.